Bird flu isn’t part of the “quad-demic” of viruses circulating through the country this winter—COVID, seasonal flu, ...
The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.
The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.
Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...
The number of bird flu cases in Central Massachusetts is relatively low, compared to a swath of the state that runs from ...
Moderna plans to advance research on the mRNA vaccine into a phase 3 trial after receiving positive results in earlier phases ...
Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...
The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains ...
The Centers for Disease Control and Prevention abruptly ordered its staff to cease all collaboration with the World Health ...
Concerns about bird flu are growing among health officials weeks after the first person in the U.S. died from the virus, and ...
MRNA intends to use the funds to support the development of its mRNA-based bird flu shot and expand clinical studies for ...
The U.S. Department of Health and Human Services announced it will award $590 million to Moderna to accelerate the ...